Bowhead Specialty Holdings Inc. (NYSE:BOW) Receives Consensus Rating of “Moderate Buy” from Brokerages

Bowhead Specialty Holdings Inc. (NYSE:BOWGet Free Report) has been assigned an average rating of “Moderate Buy” from the nine analysts that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $32.00.

BOW has been the topic of several recent analyst reports. Keefe, Bruyette & Woods increased their price objective on Bowhead Specialty from $34.00 to $36.00 and gave the company an “outperform” rating in a research report on Wednesday. Piper Sandler boosted their target price on Bowhead Specialty from $28.00 to $32.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 26th. Weiss Ratings upgraded shares of Bowhead Specialty from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 23rd. Citizens Jmp dropped their price target on shares of Bowhead Specialty from $38.00 to $35.00 and set a “market outperform” rating on the stock in a report on Monday, April 13th. Finally, UBS Group set a $28.00 price target on shares of Bowhead Specialty in a research note on Thursday, May 21st.

View Our Latest Stock Analysis on Bowhead Specialty

Bowhead Specialty Stock Performance

BOW stock opened at $32.20 on Friday. The stock has a market capitalization of $1.06 billion, a PE ratio of 18.61, a price-to-earnings-growth ratio of 0.95 and a beta of -0.10. Bowhead Specialty has a 12-month low of $21.21 and a 12-month high of $34.71. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 0.32. The stock’s 50 day simple moving average is $27.79 and its 200 day simple moving average is $25.70.

Bowhead Specialty (NYSE:BOWGet Free Report) last posted its earnings results on Tuesday, May 5th. The company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.06. Bowhead Specialty had a return on equity of 13.80% and a net margin of 9.99%.The business had revenue of $155.69 million during the quarter, compared to analyst estimates of $211.74 million. As a group, research analysts forecast that Bowhead Specialty will post 1.97 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Langdon Equity Partners purchased a new position in shares of Bowhead Specialty during the 4th quarter worth $28,000. Versant Capital Management Inc increased its stake in shares of Bowhead Specialty by 262.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,037 shares of the company’s stock worth $31,000 after purchasing an additional 751 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Bowhead Specialty in the 2nd quarter worth $52,000. CWM LLC increased its stake in shares of Bowhead Specialty by 257.7% in the 4th quarter. CWM LLC now owns 1,481 shares of the company’s stock worth $42,000 after purchasing an additional 1,067 shares in the last quarter. Finally, Parallel Advisors LLC raised its holdings in Bowhead Specialty by 181.4% in the 1st quarter. Parallel Advisors LLC now owns 1,652 shares of the company’s stock worth $37,000 after purchasing an additional 1,065 shares during the period.

About Bowhead Specialty

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Read More

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.